CATALOGO DEI PRODOTTI DELLA RICERCA

CALABRESE, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.845
NA - Nord America 5.023
AS - Asia 4.116
SA - Sud America 690
AF - Africa 161
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.876
RU - Federazione Russa 2.627
SG - Singapore 1.580
CN - Cina 1.251
GB - Regno Unito 684
IT - Italia 646
BR - Brasile 578
HK - Hong Kong 422
DE - Germania 383
SE - Svezia 327
FR - Francia 301
VN - Vietnam 290
FI - Finlandia 280
IE - Irlanda 256
KR - Corea 126
TR - Turchia 124
CA - Canada 82
ID - Indonesia 76
UA - Ucraina 59
AT - Austria 52
NL - Olanda 51
AR - Argentina 49
IN - India 49
JP - Giappone 48
PL - Polonia 48
MX - Messico 43
ZA - Sudafrica 40
TG - Togo 35
ES - Italia 34
BJ - Benin 32
BD - Bangladesh 25
BE - Belgio 22
EC - Ecuador 16
AE - Emirati Arabi Uniti 14
MA - Marocco 14
UZ - Uzbekistan 13
CO - Colombia 12
PY - Paraguay 12
LT - Lituania 11
MK - Macedonia 11
AU - Australia 10
AZ - Azerbaigian 10
IQ - Iraq 10
EG - Egitto 9
IL - Israele 8
KE - Kenya 8
CZ - Repubblica Ceca 7
HR - Croazia 7
PK - Pakistan 7
CL - Cile 6
JO - Giordania 6
PT - Portogallo 6
QA - Qatar 6
SA - Arabia Saudita 6
CH - Svizzera 5
DZ - Algeria 5
PE - Perù 5
PH - Filippine 5
CY - Cipro 4
DO - Repubblica Dominicana 4
GY - Guiana 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
KG - Kirghizistan 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
OM - Oman 3
RO - Romania 3
TW - Taiwan 3
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
GD - Grenada 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
LU - Lussemburgo 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
Totale 15.829
Salva come PNG Salva come JPEG
Città #
Moscow 919
Chandler 682
Dallas 644
Ashburn 587
Singapore 560
Southend 490
Hong Kong 417
Beijing 265
Dublin 252
Verona 221
Munich 186
Jacksonville 165
Woodbridge 151
Helsinki 149
Ann Arbor 133
Los Angeles 130
New York 130
Princeton 100
Redmond 97
Houston 93
Lawrence 93
Istanbul 92
The Dalles 81
São Paulo 79
Wilmington 79
Ho Chi Minh City 74
Jinan 71
Redondo Beach 68
Jakarta 62
Buffalo 55
Dong Ket 52
London 50
Hanoi 48
Nanjing 48
Lancaster 45
Shenyang 44
Sindelfingen 44
Lappeenranta 43
Santa Clara 43
Warsaw 43
Tianjin 42
Columbus 41
Milan 41
Turku 41
Montreal 40
Hebei 39
Seattle 38
Tokyo 38
Lomé 35
Council Bluffs 33
Cotonou 32
Johannesburg 32
Redwood City 32
Washington 32
Nuremberg 30
Brooklyn 29
Seoul 29
Atlanta 28
Changsha 27
Chicago 26
Denver 26
Vienna 26
Zhengzhou 26
Chennai 25
Haikou 25
Guangzhou 24
Ningbo 24
Amsterdam 23
Stockholm 22
Taizhou 22
Brussels 21
Phoenix 21
Boardman 20
Nanchang 19
Poplar 19
Falkenstein 17
Hangzhou 17
Mexico City 17
Norwalk 17
Paris 17
Bologna 16
Rome 16
Ankara 15
Haiphong 15
Manchester 15
San Francisco 15
Des Moines 14
Dongguan 14
Rio de Janeiro 14
Orem 13
Padova 13
Sant'Ambrogio di Valpolicella 13
Toronto 13
Belo Horizonte 12
Frankfurt am Main 12
Fuzhou 12
Porto Alegre 12
Taiyuan 12
Boston 11
Brasília 11
Totale 8.966
Salva come PNG Salva come JPEG
Nome #
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 365
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 253
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 213
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 184
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 182
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 179
A case of acute fulminant multiple sclerosis treated with alemtuzumab 176
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 175
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 175
A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia 172
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 170
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 168
Can DTI and 3D-SHORE based indices differentiate RRMS from PMS Patients? 156
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 155
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 154
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 151
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 151
Assessing response to interferon-β in a multicenter dataset of patients with MS 151
Response to Nagai et al. 149
A videogame-based approach to measuring information processing speed in multiple sclerosis patients 149
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 147
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 147
Explainable 3D-CNN for multiple sclerosis patients stratication 147
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results 145
Coping strategies and their impact on quality of life and physical disability of people with multiple sclerosis 145
Epilepsy in multiple sclerosis: The role of temporal lobe damage 145
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 142
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 140
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 139
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 138
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 138
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 135
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 135
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients 134
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 133
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 132
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 132
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 132
Visual-attentional load unveils slowed processing speed in multiple sclerosis patients: a pilot study with a tablet-based videogame 130
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 128
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 127
Interpretable Deep Learning as a means for decrypting disease signature in Multiple Sclerosis 127
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 126
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 124
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 124
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 123
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 122
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 122
Lost in classification: lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients 121
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 120
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 119
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 119
Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection 118
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 118
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 118
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 117
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 117
Correlating Dti and 3d-Shore Based Indices with Neurological Disability Scores of Multiple Sclerosis Patients 117
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 114
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 114
False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm 114
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 112
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 109
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 108
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 108
Exploring the origins of grey matter damage in multiple sclerosis. 108
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 107
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 106
"What is hidden behind the mask?" Facial emotion recognition at the time of COVID-19 pandemic in cognitively normal multiple sclerosis patients 106
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 105
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 105
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 103
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 103
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 103
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 103
Multiple sclerosis and epilepsy: much more than a coincidence 101
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 100
Impact of model selection procedure on Deep Neural Networks ensemble for the Choroid Plexus segmentation in Multiple Sclerosis 100
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 99
Explainable deep learning for decrypting disease signatures in multiple sclerosis 98
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 97
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 97
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. 97
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 96
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 95
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 94
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 93
ASCHOPLEX: A generalizable approach for the automatic segmentation of choroid plexus 93
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 92
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 92
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 92
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 92
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 91
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis 90
Multivariate data analysis suggests the link between brain microstructure and cognitive impairment in multiple sclerosis 89
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 89
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 89
Heterogeneity of cortical lesions in multiple sclerosis: An MRI perfusion study 88
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 88
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 86
Totale 12.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.281
article - articoli 55.957
book - libri 0
conference - conferenze 5.917
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 407
Totale 124.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 95 75 32 20 49 34 68 79
2021/2022870 48 263 5 125 18 19 34 53 27 30 64 184
2022/20231.895 116 244 158 337 129 415 45 114 220 22 53 42
2023/20241.235 38 88 105 132 124 238 102 77 17 94 154 66
2024/20253.674 140 169 144 615 159 203 205 223 620 250 315 631
2025/20266.249 720 580 722 1.847 2.380 0 0 0 0 0 0 0
Totale 16.120